The global venous thromboembolism market size was valued at USD 7.50 billion in 2025 and is expected to reach USD 11.38 billion by 2033, at a CAGR of 5.36% during the forecast period
The market growth is largely fueled by the rising incidence of venous disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE), along with increasing prevalence of risk factors including obesity, cancer, prolonged immobility, and aging populations, leading to greater demand for effective prevention and treatment solutions across healthcare settings
Furthermore, growing awareness of early diagnosis, rising adoption of anticoagulant therapies, and increasing use of compression devices and advanced diagnostic imaging are establishing Venous Thromboembolism management as a critical component of cardiovascular care. These converging factors are accelerating the uptake of Venous Thromboembolism solutions, thereby significantly boosting the industry's growth